1. Home
  2. ACXP vs AGH Comparison

ACXP vs AGH Comparison

Compare ACXP & AGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • AGH
  • Stock Information
  • Founded
  • ACXP 2017
  • AGH 2014
  • Country
  • ACXP United States
  • AGH United States
  • Employees
  • ACXP N/A
  • AGH N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • AGH
  • Sector
  • ACXP Health Care
  • AGH
  • Exchange
  • ACXP Nasdaq
  • AGH NYSE
  • Market Cap
  • ACXP 8.4M
  • AGH 9.0M
  • IPO Year
  • ACXP 2021
  • AGH 2025
  • Fundamental
  • Price
  • ACXP $0.35
  • AGH $0.64
  • Analyst Decision
  • ACXP Strong Buy
  • AGH
  • Analyst Count
  • ACXP 2
  • AGH 0
  • Target Price
  • ACXP $10.00
  • AGH N/A
  • AVG Volume (30 Days)
  • ACXP 235.0K
  • AGH 313.2K
  • Earning Date
  • ACXP 05-13-2025
  • AGH 05-15-2025
  • Dividend Yield
  • ACXP N/A
  • AGH N/A
  • EPS Growth
  • ACXP N/A
  • AGH N/A
  • EPS
  • ACXP N/A
  • AGH N/A
  • Revenue
  • ACXP N/A
  • AGH $3,073,097.00
  • Revenue This Year
  • ACXP N/A
  • AGH N/A
  • Revenue Next Year
  • ACXP N/A
  • AGH N/A
  • P/E Ratio
  • ACXP N/A
  • AGH N/A
  • Revenue Growth
  • ACXP N/A
  • AGH N/A
  • 52 Week Low
  • ACXP $0.30
  • AGH $0.52
  • 52 Week High
  • ACXP $3.33
  • AGH $7.22
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 37.87
  • AGH N/A
  • Support Level
  • ACXP $0.34
  • AGH N/A
  • Resistance Level
  • ACXP $0.36
  • AGH N/A
  • Average True Range (ATR)
  • ACXP 0.02
  • AGH 0.00
  • MACD
  • ACXP -0.00
  • AGH 0.00
  • Stochastic Oscillator
  • ACXP 5.19
  • AGH 0.00

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About AGH AUREUS GREENWAY HOLDINGS INC

Aureus Greenway Holdings Inc own and operate two public golf country clubs in Florida. The golf country clubs include two golf-courses with over 13,000 yards of combined fairways, clubhouses boasting food and beverage options, aquatic golf ranges, and pro shops to assist any level of golfer and also host local golf leagues, golf-tournaments, and private events. Its golf country clubs is organized into four principal business segments: (i) golf recreation, retail golf products, and equipment and facilities rental, (ii) membership dues, (iii) food and beverage services. and (iv) ancillary services and amenities. All assets of the Company are located in Florida and all revenue is generated from Florida.

Share on Social Networks: